Health economics of screening for hypertension in Vietnam by Nguyen, Thi Phuong Lan
  
 University of Groningen
Health economics of screening for hypertension in Vietnam
Nguyen, Thi Phuong Lan
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Nguyen, T. P. L. (2016). Health economics of screening for hypertension in Vietnam. [Groningen]:
University of Groningen.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




Models to predict the burden of 
cardiovascular disease risk in a rural 
mountainous region of Vietnam
Thi-Phuong-Lan Nguyen, C.C.M.Schuiling-Veninga,
Thi-Bach-Yen-Nguyen, Thu-Hang Vu, E.P.Wright, M.J. Postma
Value in Health Regional Issues:
Volume 3, May 2014, Pages 87–93
20





To compare and identify the most appropriate model to predict 
cardiovascular disease in a rural area in Northern Vietnam, using data 
on hypertension from the communities.
Methods
A cross sectional survey was conducted including all residents in 
selected communities, aged 35 to 64 years, during April to August 
2012 in Thai Nguyen province. Data on age, sex, smoking status, 
blood pressure, and blood tests (glucose, total cholesterol, low-density 
lipoprotein cholesterol, high-density lipoprotein) were collected to 
identify prevalence of high blood pressure and to use as input 
variables for the models. We compared three models: Asian, Chinese 
Multiple-provincial Cohort Study (CMCS) and Framingham, to 
estimate cardiovascular risk in the coming years in this context and 
compare these models and outcomes.  
Results
The prevalence of high blood pressure in these communities was 
lower than reported nationally (12.3%). CVD risk differed greatly 
depending on the model applied: approximately 21% of subjects 
according to the CMCS and Asian models, but 37% using the 
Framingham model had more than 10% risk for CVD. In the group 
without current CVD, these numbers decreased to 9% using the 
CMCS and Asian models, but 28% according to the Framingham 
model. There were no significant differences between the Asian and 
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CMCS models but differences were highly significant when 
comparing Asian vs. Framingham or CMCS vs. Framingham model. 
Conclusion
The Asian and CMCS models provided similar results in predicting 
CVD risk in the Vietnamese population in Thai Nguyen. The 
Framingham model provided vastly different results and might be less 
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CMCS models but differences were highly significant when 
comparing Asian vs. Framingham or CMCS vs. Framingham model. 
Conclusion
The Asian and CMCS models provided similar results in predicting 
CVD risk in the Vietnamese population in Thai Nguyen. The 
Framingham model provided vastly different results and might be less 
suitable for these populations.
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The burden of cardiovascular diseases (CVD) is increasing 
worldwide; it is a leading cause of death both globally and in Asian 
countries [1-3]. Of all CVD, ischemic heart disease and 
cerebrovascular disease/stroke were the most common causes of death 
in 1990 and 2010. The mortality rate of both diseases has increased 
over the past two decades: approximately 35% for ischemic heart 
disease and 26% for stroke. In 2010, both diseases also belonged to 
the top five causes of years of life lost [1]. Hypertensive heart disease 
increased from 18.3 in 1990 to 14.2 in 2010 in the global ranking of 
causes of death. In Vietnam, CVD was among the top 10 leading 
causes of death in 2006, 2007 and 2009 [4, 5]. Around 32% of deaths 
from non-communicable diseases in rural areas are caused by 
cardiovascular diseases [6, 7].
To make best use of limited resources, planning of health care 
interventions is important. Predictive modeling of the risk of CVD can 
render valuable information for planning these health interventions.
The first step in the prediction of the CVD risk is the selection of the 
best-fitting model for the Vietnamese population. Over the last 
decade, several models have been developed and validated. The first 
well-known model was developed in the US using data from the 
Framingham study. However, this model might be less reliable in 
other populations and has overestimated or underestimated the CVD 
risks in specific settings [8, 9]. Therefore, other models were 
developed, such as the SCORE in Europe[10], QRISK in the United 
Kingdom [11], PROCAM in Germany [12], ASSIGN in Scotland 
[13], and CUORE in Italy [14]. In Asia, models to predict CVD risk 
have been developed in Thailand, China (Chinese Multiple-provincial 
Cohort Study (CMCS)), Japan, Malaysia, and Singapore. For all Asian 
populations, a tool was developed based on six cohorts in this region 
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(Asian Model) [8, 15-21]. As all these models vary in different aspects 
like the time horizon used, characteristics of study population 
included, input variables, and outcome, they may all produce different 
results. In Vietnam, with its own environment of biological, 
behavioral and social characteristics, there is not yet a specific model 
to predict CVD. The largest survey on risk factors for CVD done in 
Vietnam applied the Framingham model only [22]. Also, the 
Framingham model is explicitly introduced on the Vietnam Heart 
Association website. The aim of this study is to calculate the CVD 
risk using two prediction models developed in Asia and assess to what 
extent these results coincides with CVD risks calculated using the 
long-established Framingham model. In this way, we hope to identify 
the most suitable model to predict future patterns of disease for health 
planners in Vietnam. 
The second step for modeling of the CVD risk is information on risk 
factors and demographic characteristics of the population. It is well-
known that improved CVD management could be approached through 
changing life style. Additionally, there are concerns on the capacity of 
health services to adequately detect risk factors such as hypertension. 
It is estimated that half of the expected 25% hypertensive individuals 
in the population are not aware of their hypertension [23]. Better CVD 
management is public health concern and hypertension detection and 
treatment are crucial elements in that management. There have been 
large surveys on hypertension in Vietnam [22, 23]. This report 
describes a smaller but potentially more intensive study. A specific 
sub-aim of our study was to collect complete and reliable data to 
assess the prevalence of hypertension and distribution of risk factors 
in four rural communities, in a mountainous area in the North of 










The burden of cardiovascular diseases (CVD) is increasing 
worldwide; it is a leading cause of death both globally and in Asian 
countries [1-3]. Of all CVD, ischemic heart disease and 
cerebrovascular disease/stroke were the most common causes of death 
in 1990 and 2010. The mortality rate of both diseases has increased 
over the past two decades: approximately 35% for ischemic heart 
disease and 26% for stroke. In 2010, both diseases also belonged to 
the top five causes of years of life lost [1]. Hypertensive heart disease 
increased from 18.3 in 1990 to 14.2 in 2010 in the global ranking of 
causes of death. In Vietnam, CVD was among the top 10 leading 
causes of death in 2006, 2007 and 2009 [4, 5]. Around 32% of deaths 
from non-communicable diseases in rural areas are caused by 
cardiovascular diseases [6, 7].
To make best use of limited resources, planning of health care 
interventions is important. Predictive modeling of the risk of CVD can 
render valuable information for planning these health interventions.
The first step in the prediction of the CVD risk is the selection of the 
best-fitting model for the Vietnamese population. Over the last 
decade, several models have been developed and validated. The first 
well-known model was developed in the US using data from the 
Framingham study. However, this model might be less reliable in 
other populations and has overestimated or underestimated the CVD 
risks in specific settings [8, 9]. Therefore, other models were 
developed, such as the SCORE in Europe[10], QRISK in the United 
Kingdom [11], PROCAM in Germany [12], ASSIGN in Scotland 
[13], and CUORE in Italy [14]. In Asia, models to predict CVD risk 
have been developed in Thailand, China (Chinese Multiple-provincial 
Cohort Study (CMCS)), Japan, Malaysia, and Singapore. For all Asian 
populations, a tool was developed based on six cohorts in this region 
Chapter 2 
 
(Asian Model) [8, 15-21]. As all these models vary in different aspects 
like the time horizon used, characteristics of study population 
included, input variables, and outcome, they may all produce different 
results. In Vietnam, with its own environment of biological, 
behavioral and social characteristics, there is not yet a specific model 
to predict CVD. The largest survey on risk factors for CVD done in 
Vietnam applied the Framingham model only [22]. Also, the 
Framingham model is explicitly introduced on the Vietnam Heart 
Association website. The aim of this study is to calculate the CVD 
risk using two prediction models developed in Asia and assess to what 
extent these results coincides with CVD risks calculated using the 
long-established Framingham model. In this way, we hope to identify 
the most suitable model to predict future patterns of disease for health 
planners in Vietnam. 
The second step for modeling of the CVD risk is information on risk 
factors and demographic characteristics of the population. It is well-
known that improved CVD management could be approached through 
changing life style. Additionally, there are concerns on the capacity of 
health services to adequately detect risk factors such as hypertension. 
It is estimated that half of the expected 25% hypertensive individuals 
in the population are not aware of their hypertension [23]. Better CVD 
management is public health concern and hypertension detection and 
treatment are crucial elements in that management. There have been 
large surveys on hypertension in Vietnam [22, 23]. This report 
describes a smaller but potentially more intensive study. A specific 
sub-aim of our study was to collect complete and reliable data to 
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As described above, several CVD prediction models are available 
around the world. In this study, we selected two models developed in 
Asia, because their target populations may share a similar background 
of disease and risk factors for CVD to Vietnam. This would avert the 
potential over- or underestimation that may appear when the 
Framingham model or others developed for Western countries are 
used. The Asian model was validated based on six cohorts in Asia and 
may be most representative for Asian countries. The Chinese 
Multiple-provincial Cohort Study (CMCS) model was developed 
based on cohorts in 11 provinces in China. We are interested in this 
model as well because Vietnamese share a background of mortality 
patterns with the Chinese: CVD was 40% in Vietnam and 38% in 
China among deaths due to non-communicable disease, which account 
for 80% of all deaths in China and 75% of all deaths in Vietnam. Age-
standardized death rate per 100,000 due to CVD and diabetes was 
similar in China and Vietnam (male: 311.5 and 381.5 in China and 
Vietnam; female: 259.6 and 298.2 in China and Vietnam, 
respectively). High BP in 2010 was 38.2% in China and 33% in 
Vietnam. Patterns of obesity or overweight may, however, be different 
[24, 25].
We also applied the Framingham model, which is widely used and 
also - as mentioned - is presented on the Vietnam Heart Association 
website. This tool was developed from cohort of Americans who were 
free of coronary heart disease and diabetes, to predict the 10-year risk 
of myocardial infarction and coronary heart death. 
Risk factors included in the models differ to some extent. Information 
on sex, age and smoking status is, however, included in all three 
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models. Furthermore, the CMCS model also includes information on 
diabetes, stage of hypertension, total cholesterol, and high-density 
lipoprotein cholesterol. In the Asian model, systolic blood pressure 
and total cholesterol are used as input variables. In the Framingham 
model, the following variables are used: total cholesterol, high-density 
lipoprotein cholesterol and systolic blood pressure. 
We calculated the CVD risk of each individual using equations of 
CMCS and Asian model which consider above input variables, and 
their own mean survival rate, the regression coefficients, and mean 
values of the risk factors in CMCS or Asian models. In the 
Framingham model, we calculated the point score of each input 
variable and translated point scores into risk levels, guided by the 
Framingham Heart Study. The CMCS, Asian and Framingham models 
have been described in detail [8, 26, 27].
The CVD risk was assessed using all three models for two scenarios. 
The base case excluded all cases with current CVD, whereas in the 
sensitivity analysis all cases, both with and without current CVD, 
were included. 
Study population and study design
A cross sectional study was conducted from April to August 2012 in 
Thai Nguyen, a mountainous province in the North of Vietnam. Four 
districts, all around 40 kilometers from Thai Nguyen city, were 
purposively selected; we then chose one commune in the middle of 
each district. Within each commune, all villages having an active 
health care worker were listed. From this list, we selected randomly 
enough villages to cover 45 to 50% of the total population in that 
commune. 
All residents from 35 to 64 years old in each village were invited to 
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medical history or alcohol consumption, were current pregnancy, 
mental health disease, heavy alcohol consumption (often drunk), 
cancer, AIDS, current treatment of hypertension or diabetes, or a 
medical history of myocardial infarction, stroke, heart failure or 
kidney failure.
Medical students and village health workers, who were trained on 
blood pressure (BP) measurement and on using the study 
questionnaires, collected data at a village center or in the household. 
Data were collected on demographic characteristics (sex, age, 
ethnicity, education, occupation, and residence), risk factors for CVD 
(smoking, alcohol consumption) and BP was measured. All subjects 
who had systolic blood pressure (SBP) ≥140 mm Hg and/or diastolic 
blood pressure (DBP) ≥90 mm Hg were invited to visit the community 
health center for a second BP measurement, 5 to 7 days after the first 
measurement. All subjects who still had SBP ≥140 mm Hg and/or 
DBP ≥90 mm Hg on the second day were medically examined 
including an ECG and blood samples were collected. These people 
were advised to manage high BP at their community health center or 
were referred to a higher level for further investigation. All subjects 
who had SBP < 140 mm Hg and/or DBP < 90 mm Hg were advised to 
check their BP regularly. 
Measurement and classification
BP measurement: Participants were advised to avoid drinking alcohol 
the day before the visit, and to stop cigarette smoking, drinking 
coffee/tea and taking exercise for at least 30 minutes before their BP 
measurement. Automatic sphygmomanometers (OMRON, model 
HEM-7200-C1, Healthcare, Japan) with an appropriate sized cuff 
were used. BP was measured twice for everyone, with participants in a 
sitting position after at least 10 minutes of rest. A third measurement 
was performed if the difference between the first two was over 10 
Chapter 2 
 
mmHg for SBP or DBP. Average SBP and/or DBP of the first and 
second or second and third measurements were used for analysis [28, 
29]. Hypertension was defined as value of SBP ≥ 140 mm Hg and/or 
DBP ≥90 mm Hg on the second visit. It has been recommended that in 
a setting of scarce resources, the value of blood pressure at the second 
visit would be suitable for a reliable measurement of the real 
prevalence of hypertension in the community [30]. Hypertension was 
classified according to the Seventh Joint National Committee on 
Hypertension Classification[31].
Occupations were assigned to one of seven categories: farmer, worker, 
businessperson, wage earner, housewife, government officer, and 
other. 
In the second visit, patients were examined by medical doctors from 
Thai Nguyen University of Medicine and Pharmacy. For this study, 
we defined coronary heart disease (including angina, left ventricular 
hypertrophy, myocardial infarction, or heart failure) by medical 
history, physical examination and result of electrocardiogram. Blood 
tests (glucose, total cholesterol, low-density lipoprotein cholesterol, 
high-density lipoprotein) were performed by a team from Thai 
Nguyen General Hospital. Diabetes was defined as fasting blood 
glucose level ≥ 7 mmol/l [32]. Subjects who smoked cigarettes or pipe 
during the last month were defined as current smokers.
Statistical analysis
Chi square, student’s t-test or Mann-Whitney test were used to 
compare differences in biological factors among different visits, 
different groups, and the distribution of CVD in different models. Chi 
square testing was used to compare model differences. Based on the 
Guideline for Assessment and Management of Cardiovascular Risk, 
we used 10% as cutoff point for CVD risks over a 10-year period. In 
particular, it is stated that with a 10-year risk of CVD greater than 
10%, subjects need to be monitored regularly [33]. All statistical 
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The research proposal was approved by the Institutional Review 
Board in biomedical research in the Institute of Social and Medical 
Studies in Vietnam. The study was explained to all those invited to 
join, and all subjects signed a consent form before participating in the 
study. All participants had the right to withdraw from the study at any 
time. Patients who were found to have high BP were advised to 
manage it at their community health station or were referred to a 
higher level for specialist examination if needed. Subjects without 
high BP were advised to monitor their BP regularly.
Results
Study population characteristics
As shown in Fig 1, the 3,779 subjects who participated in the study 
comprised 86.5 % of all those who were invited. They included 43.3% 
males and 84% was ethnically Kinh (the majority ethnic group in 
Vietnam). The most common occupation (72.5%) was farmer and the 
mean age was 47.4 ± 8 years. 
Chapter 2 
 
Fig 1: Flow chart of selecting the final sample
Notes: We selected all subjects with hypertension in the second measurement. We 
required blood samples from all cases to have values for all variables to be included 
in the analysis with three models. 
In this study, hypertension prevalence is a key factor and an important 
input variable. We therefore first present the data on hypertension 
prevalence, followed by the CVD model results. 




589 subjects declined to 
participate the screening
 Attended the screening: 
3779 subjects 
(3779*100/4386 = 86.5%)
3003 subjects without 
hypertension in the first 
measurement
Hypertension during the first 
measurement: 776 subjects 
(776*100/3779=20.5%)
10 subjects not followed 
up and 300 subjects 
without hypertension in 
the second measurement
Hypertension during the second 
measurement: 466 subjects 
(466*100/766=60.8%)
24 subjects did not 
provide blood samples
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The distribution of BP among 3779 subjects in the first visit is 
presented in Table 1. Among this study population, 776 subjects 
(20.5%) had SBP ≥140 mm Hg and/or DBP ≥ 90 mm Hg during the 
first visit. The prevalence of elevate BP was greater among men than 
women  (28.3% vs. 14.6%, p<0.001) and increased with age (10.5%, 
23.9%, 33.4% in 35-44, 45-54 and 55-64 age groups, respectively, 
p<0.001). During the second visit, at which 766 subjects appeared, 
466 subjects (60.8%) still had a high BP. Using the BP values of this 
second visit, the overall prevalence of hypertension in the total 
population (3779 subjects) was 12.3%, including 16% of men and 
9.6% of women (p<0.001).
Table 1: Prevalence of blood pressure classification in study population,
stratified by sex and age group (%) at 1st visit (n=3779)
Normal Prehypertension Stage 1 Stage 2 p value
Men
35-44 30.6 52.9 13.2 3.3
0.00045-54 22.0 45.2 21.8 11.0
55-64 19.1 38.0 26.0 16.9
Women
35-44 64.5 29.6 4.3 1.5
0.00045-54 46.7 36.0 12.6 4.7
55-64 36.5 37.3 18.1 8.1
Total
Men 24.9 46.8 19.2 9.1
0.000
Women 51.7 33.7 10.5 4.2
Both sexes 40.1 39.4 14.2 6.3
Note: Blood pressure level was clasified according to JNC 7: Normal: 
SBP/DBP<120/80 mm Hg; Prehypertension: SBP/DBP is 120-139/80-89 mm Hg; 
Stage 1: SBP/DBP is 140-159/90-99 mm Hg; Stage 2: SBP/DBP ≥160/100 mm Hg; 
men vs women: p=0.000; 
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Both the median and mean value of the SBP and DBP were lower at 
the second visit compared to measurements during the first visit 
(mean: 151.3 mm Hg and 147.7 mm Hg; median: 148 mm Hg and 145 
mm Hg in the first and second visits respectively, p<0.001). However, 
the range of BP in the second visit was greater than in the first visit. 
Biological factors among hypertensive subjects (at second 
measurement) are presented in Table 2. As blood tests of 24 subjects 
were missing, data on only 442 subjects are presented. Age, fasting 
glucose, and SBP were comparable between men and women 
(p>0.05). Total cholesterol and LDL-cholesterol were lower in men 
(p<0.05 and p<0.01 respectively) whereas HDL-cholesterol was 
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first visit. The prevalence of elevate BP was greater among men than 
women  (28.3% vs. 14.6%, p<0.001) and increased with age (10.5%, 
23.9%, 33.4% in 35-44, 45-54 and 55-64 age groups, respectively, 
p<0.001). During the second visit, at which 766 subjects appeared, 
466 subjects (60.8%) still had a high BP. Using the BP values of this 
second visit, the overall prevalence of hypertension in the total 
population (3779 subjects) was 12.3%, including 16% of men and 
9.6% of women (p<0.001).
Table 1: Prevalence of blood pressure classification in study population,
stratified by sex and age group (%) at 1st visit (n=3779)
Normal Prehypertension Stage 1 Stage 2 p value
Men
35-44 30.6 52.9 13.2 3.3
0.00045-54 22.0 45.2 21.8 11.0
55-64 19.1 38.0 26.0 16.9
Women
35-44 64.5 29.6 4.3 1.5
0.00045-54 46.7 36.0 12.6 4.7
55-64 36.5 37.3 18.1 8.1
Total
Men 24.9 46.8 19.2 9.1
0.000
Women 51.7 33.7 10.5 4.2
Both sexes 40.1 39.4 14.2 6.3
Note: Blood pressure level was clasified according to JNC 7: Normal: 
SBP/DBP<120/80 mm Hg; Prehypertension: SBP/DBP is 120-139/80-89 mm Hg; 
Stage 1: SBP/DBP is 140-159/90-99 mm Hg; Stage 2: SBP/DBP ≥160/100 mm Hg; 
men vs women: p=0.000; 
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Both the median and mean value of the SBP and DBP were lower at 
the second visit compared to measurements during the first visit 
(mean: 151.3 mm Hg and 147.7 mm Hg; median: 148 mm Hg and 145 
mm Hg in the first and second visits respectively, p<0.001). However, 
the range of BP in the second visit was greater than in the first visit. 
Biological factors among hypertensive subjects (at second 
measurement) are presented in Table 2. As blood tests of 24 subjects 
were missing, data on only 442 subjects are presented. Age, fasting 
glucose, and SBP were comparable between men and women 
(p>0.05). Total cholesterol and LDL-cholesterol were lower in men 
(p<0.05 and p<0.01 respectively) whereas HDL-cholesterol was 
higher in men (p<0.05). 
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Stage of hypertension  (cases)     CMCS, Framingham
SBP 140 – 159 
mm Hg    or DBP  
90 – 99 mmHg
132 116 248
0.344
SBP  ≥160 mm Hg or 
DBP  ≥ 100mmHg
112 82 194










TC  (cases)                               CMCS, Framingham
<160 (mg/dL) 59 36 95 0.127
160 – 199 (mg/dL) 93 64 157 0.206
200 – 239 (mg/dL) 58 60 118 0.123
240 – 279 (mg/dL) 23 28 51 0.123
≥ 280 (mg/dL) 11 10 21 0.790
HDL-C  (cases)                         CMCS, Framingham
< 35 (mg/dL) 21 22 43 0.377
35 – 44 (mg/dL) 63 58 121 0.415
45 – 49 (mg/dL) 45 35 80 0.835
50 – 59 (mg/dL) 57 53 110 0.410
≥ 60 (mg/dL) 58 30 88 0.024
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Comparison of future patterns of CVD using CMCS, Asian and 
Framingham model
Risks of coronary heart disease were estimated using three models: the 
CMCS, Asian and Framingham models. In the base case, we excluded 
cases with a diagnosis of CVD at the time of examination in the 
second visit in all models (Table 3). The prevalence of ‘more than 
10% CVD risk’ when the Framingham model was applied was 
28.24%, higher than for the CMCS (11.7 %) and Asian models 
((9.1%). For women, 24.6% were at ‘more than 10% CVD risk’ 
according to the CMCS model, compared to only 1.6% and 0.5% in 
the Asian and Framingham models. In the age group 55 to 64 years, 
the prevalence of ‘more than 10% at CVD risk’ was highest (46%) 
using the Framingham model and lowest (15.3%) with the Asian 
model. The differences in the results between CMCS model vs. 
Framingham model and Asian model vs. Framingham model were 
highly significant (p<0.001). There were, however, no significant 
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In the sensitivity analysis, we included cases with a diagnosis of CVD 
at the examination in the second visit in each of the three models, and 
placed those cases in groups with more than 10% CVD risk (Table 4). 
The prevalence of the group with ‘more than 10% CVD risk’ was 
highest in the Framingham model (22.2%, 20.6% and 37.3% in 
CMCS, Asian and Framingham respectively; p<0.01).The prevalence 
of the group ‘more than 10% CVD risk’ in women was similar in the 
Asian and Framingham models (8% and 9% in Framingham and 
Asian respectively) but it was three times higher when the CMCS 
model was used (30.3%). In contrast, the prevalence of ‘more than 
10% CVD risk’ in men was lowest using the CMCS model (16.8%)
and highest using the Framingham model (61.07%). CVD risk 
increased with age at all models (p<0.001). In the group from 55 to 64 
years old, the prevalence of ‘more than 10% CVD risk’ was 25.4%, 
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Hypertension is key risk factor for CVD, which is a leading cause of 
death in Asia and in Vietnam. Prediction of CVD risk by using the 
most appropriate model for Vietnamese population would support 
management of CVD, in curative and preventive health care. In this 
study, we predicted CVD risk among hypertensive patients by using 
and comparing three established prediction models. 
BP measurements were taken during a first visit to the community and 
for those with high BP, again on a second visit a few days later [30].
The prevalence of high BP decreased from 20.5% in the first visit to 
12.3% in the second visit, which is low compared to results from 
previously reported studies in Vietnam (25.1% and 26.4%) [22, 23].
The difference could be explained by differences in study methods 
and geographical setting. A previous study used sampling in a 
population ≥ 25 years old, in both urban and rural areas; blood tests 
were conducted in 20% of the urban study population, and BP was 
measured during one visit. Our study was conducted in a rural 
mountainous area, measuring all of the village population from 34 to 
65 years old, and the BP was measured on two separate occasions in 
all subjects with high BP in the first visit. The prevalence of high BP 
in our study was within the range reported in other low and middle 
income countries in Asia (15%, 29% and 44.6% in Cambodia, 
Malaysia and Mongolia respectively) [34]. Again, these studies only 
measured the BP at a single visit, which may lead to overestimates of 
high BP prevalence. This finding suggests that researchers must be 
careful in identifying burden of disease in a specific setting and group; 
accurate data are needed for planning and allocation of scarce 
resources.  
CVD risk differed largely depending on the model applied: 

































































































































































































































































































































































































Hypertension is key risk factor for CVD, which is a leading cause of 
death in Asia and in Vietnam. Prediction of CVD risk by using the 
most appropriate model for Vietnamese population would support 
management of CVD, in curative and preventive health care. In this 
study, we predicted CVD risk among hypertensive patients by using 
and comparing three established prediction models. 
BP measurements were taken during a first visit to the community and 
for those with high BP, again on a second visit a few days later [30].
The prevalence of high BP decreased from 20.5% in the first visit to 
12.3% in the second visit, which is low compared to results from 
previously reported studies in Vietnam (25.1% and 26.4%) [22, 23].
The difference could be explained by differences in study methods 
and geographical setting. A previous study used sampling in a 
population ≥ 25 years old, in both urban and rural areas; blood tests 
were conducted in 20% of the urban study population, and BP was 
measured during one visit. Our study was conducted in a rural 
mountainous area, measuring all of the village population from 34 to 
65 years old, and the BP was measured on two separate occasions in 
all subjects with high BP in the first visit. The prevalence of high BP 
in our study was within the range reported in other low and middle 
income countries in Asia (15%, 29% and 44.6% in Cambodia, 
Malaysia and Mongolia respectively) [34]. Again, these studies only 
measured the BP at a single visit, which may lead to overestimates of 
high BP prevalence. This finding suggests that researchers must be 
careful in identifying burden of disease in a specific setting and group; 
accurate data are needed for planning and allocation of scarce 
resources.  
CVD risk differed largely depending on the model applied: 
approximately 9% of subjects according to the CMCS and Asian 
38
Models to predict the burden of cardiovascular disease risk in Vietnam 
 
 
models, but using the Framingham model, 28% had a more than 10% 
risk for CVD.  The prevalence of subjects having a ‘more than 10% 
CVD risk’ in our study (9 – 28%) was lower than reported in previous 
studies in Vietnam (40.9%), possibly because they used the 
Framingham model only. It was high compared to the numbers 
reported from other Asian countries in the age group 40 to 64 years ( 
3%, 5.6%, 3.9% and 11.4% in  Cambodia, Malaysia, China and 
Mongolia respectively) [22, 34, 35]. However, this comparison is of 
only limited validity because different methods were used to estimate 
CVD risk in these studies. Studies in other Asia countries used 
WHO/ISH risk prediction charts and were aware of potential 
underestimation of CVD risk [34]. The earlier study in Vietnam may 
have overestimated CVD risk also because it only measured BP at one 
visit and only did blood tests on the urban sample. These limitations 
may present a challenge for both curative and preventive care in CVD 
management based on such data. 
In our study, inclusion or exclusion of current CVD was found to 
affect the predicted future pattern of CVD risk differently in each 
model. The results from the CMCS and Asian models were 
comparable but results from the Framingham model differed 
significantly. None of these models have yet been validated in 
Vietnam. Previous studies have suggested that applying the 
Framingham model in Europe and Asia resulted in overestimates of 
the burden of disease, where there were lower rates of CVD [8, 13, 
36-39]. The differences when using the three models can be explained 
by the different components in each model, such as characteristics of 
study population, input variables, outcome variables, time horizon, 
and values in each equation. The Asian model considers the mean age, 
SBP, total cholesterol and smoke/non-smoke; outcome is defined as 
cardiovascular death, non-fatal myocardial infarction, and non-fatal 
Chapter 2 
 
cerebrovascular events in the following eight years. The CMCS 
equation uses a subgroup of risk factors, no mean values as in the 
Asian equation, and outcome is defined as coronary death and 
myocardial infarction in the coming 10 years. 
The implication of our study is that Vietnam should of course ideally 
have its own cohort to build up its own model to predict CVD risk. 
However, due to the long time needed for that, and due to resource 
constraints, it may be legitimate to use a model from countries with 
similar contextual factors, such as the CMCS or the Asian models, to 
predict patterns of CVD risk in the coming years as a basis for 
planning and management of services in Vietnam. Applying the 
Framingham model seems to provide deviating results from both other 
models and might be less appropriate for this specific setting.  
There are limitations to our study. First, we could not confirm high BP 
using ambulatory blood pressure monitoring. However, measurements 
taken at two visits are considered acceptable for low resource settings 
[30]. Secondly, we identified cases with current CVD based only on 
medical history, clinical exam and ECG so we may have lost cases 
with CVD without clinical symptoms and signs in ECG. Finally, the 
CMCS, Asian and Framingham original models can be applied to 
general populations. In this study, we only tested them in hypertensive 
patients, which reflects a limitation of our study. Notably, this may 
reduce the generalizability of our findings. 
Conclusion
In conclusion, the prevalence of high BP in a rural mountainous area 
of Vietnam was found to be lower than previously reported for 
Vietnam, but still sufficient to warrant attention from health services. 
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cerebrovascular events in the following eight years. The CMCS 
equation uses a subgroup of risk factors, no mean values as in the 
Asian equation, and outcome is defined as coronary death and 
myocardial infarction in the coming 10 years. 
The implication of our study is that Vietnam should of course ideally 
have its own cohort to build up its own model to predict CVD risk. 
However, due to the long time needed for that, and due to resource 
constraints, it may be legitimate to use a model from countries with 
similar contextual factors, such as the CMCS or the Asian models, to 
predict patterns of CVD risk in the coming years as a basis for 
planning and management of services in Vietnam. Applying the 
Framingham model seems to provide deviating results from both other 
models and might be less appropriate for this specific setting.  
There are limitations to our study. First, we could not confirm high BP 
using ambulatory blood pressure monitoring. However, measurements 
taken at two visits are considered acceptable for low resource settings 
[30]. Secondly, we identified cases with current CVD based only on 
medical history, clinical exam and ECG so we may have lost cases 
with CVD without clinical symptoms and signs in ECG. Finally, the 
CMCS, Asian and Framingham original models can be applied to 
general populations. In this study, we only tested them in hypertensive 
patients, which reflects a limitation of our study. Notably, this may 
reduce the generalizability of our findings. 
Conclusion
In conclusion, the prevalence of high BP in a rural mountainous area 
of Vietnam was found to be lower than previously reported for 
Vietnam, but still sufficient to warrant attention from health services. 
Our results demonstrate that the Asian and CMCS models provided 
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similar outcomes in predicting CVD risk in Vietnamese population. 
Prediction of risk using the Asian and CMCS models is likely to be 
more appropriate than the Framingham for the Vietnamese context, as 
they are from the same region. Framingham provides vastly different 
results and might be less suitable for this populations. The results of 
this study are useful to health planners, and will provide a basic for a 
further study on cost-effectiveness modeling of CVD management. 
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